Your Ad Here

Cancer Research

 


Browse: Links | Articles | Images | Videos  
Statistics
Pending Links: 7
Active Links: 147
Active Articles: 12
Active Videos: 1
Total Categories: 407
Sub Categories: 392

Like It? Tag It!
Blinklist  Delicious  Digg  Furl  Google  Magnolia

Reddit  Simpy  Spurl  StumbleUpon  Technorati  Yahoo

Popular Categories
Business and Economy
Food and Beverage
Biotech and Pharmaceutical
Home and Garden
Real Estate and Property
Automotive Resources
E-commerce
Insurance Related
Accounting and Finance
Cooperatives

Site of the Day
Appareils de mesure
Appareils de mesure

You'll find lots of equipments for monitoring, analysis, detection, measurement and testing. In addition you can use our repair and calibration services.

RSS Feed


Sort by: PageRank | Hits | Alphabetical  

Links 2 Visit

Partners



Current Cancer Research News Today

Soy isoflavone supplements did not provide breast cancer protections
( American Association for Cancer Research ) Findings suggest the effects of food may be more complex. Adverse effect observed in younger women.

Fri, 03 Feb 2012 07:44:37 -0800

New partnerships to boost SA cancer fight
A $20 million campaign to boost cancer research in South Australia will involve collaboration between the three universities, the Cancer Council and the SA Government.

Thu, 02 Feb 2012 17:48:23 -0800

Research and Markets: Ovarian Cancer - Pipeline Review, H1 2012
Research and Markets has announced the addition of Global Markets Direct's new report "Ovarian Cancer - Pipeline

Fri, 03 Feb 2012 06:00:00 -0800

Government says home-grown cancer pill too costly to use
LONDON (Reuters) - Britain's health cost watchdog NICE sparked a major row on Thursday by snubbing a pricey new prostate cancer pill discovered at the country's top cancer research centre, a decision critics said was bad for patients and research. If the draft ruling is upheld after further consultation, Zytiga, which is marketed by Johnson & Johnson, will not be reimbursed on the state-run ...

Wed, 01 Feb 2012 16:04:32 -0800

UK says home-grown cancer pill too costly to use
LONDON (Reuters) - Britain's health cost watchdog NICE sparked a major row on Thursday by snubbing a pricey new prostate cancer pill discovered at the country's top cancer research centre, a decision critics said was bad for patients and research. If the draft ruling is upheld after further consultation, Zytiga, which is marketed by Johnson & Johnson, will not be reimbursed on the state-run ...

Wed, 01 Feb 2012 16:10:08 -0800